Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15 USD | +36.24% | -.--% | -.--% |
Business Summary
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Cellular Drugs
100.0
%
| 0 | 100.0 % | 6 | 100.0 % | +2,161.56% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 6 | 100.0 % | +2,161.56% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Cheng Hsiang Kao
CEO | Chief Executive Officer | - | 20-01-20 |
Pao Chi Chu
CHM | Chairman | 70 | 20-01-20 |
Jer Li Lin
CTO | Chief Tech/Sci/R&D Officer | - | 20-01-20 |
Yen Xun Chen
PRN | Corporate Officer/Principal | - | 20-01-20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Pao Chi Chu
CHM | Chairman | 70 | 20-01-20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 206,520,030 | 85,148,035 ( 41.23 %) | 0 | 41.23 % |
Company contact information
VitaSpring Biomedical Co. Ltd.
400 Spectrum Center Drive Suite 1620
92618, Irvine
+
Sector
1st Jan change | Capi. | |
---|---|---|
-.--% | 3.11B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- VSBC Stock
- Company VitaSpring Biomedical Co. Ltd.